Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Deferred Tax Assets (2016)

Wave Life Sciences' Current Deferred Tax Assets history spans 2 years, with the latest figure at $214000.0 for Q4 2016.

  • For Q4 2016, Current Deferred Tax Assets rose 1088.89% year-over-year to $214000.0; the TTM value through Dec 2016 reached $214000.0, up 1088.89%, while the annual FY2016 figure was $214000.0, 1088.89% up from the prior year.
  • Current Deferred Tax Assets reached $214000.0 in Q4 2016 per WVE's latest filing, up from $23000.0 in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $214000.0 in Q4 2016 to a low of $18000.0 in Q4 2015.